Eyewire Today

Advertisement

EyewireTV — Eylea FDA Approval for DME, New Cassini Functionality, Simbrinza EU Approval

Video Thumnail

In this week's EyewireTV, Regeneron receives FDA approval for Eylea for the treatment of diabetic macular edema; and I-Optics launches a new functionality for its Cassini corneal shape analyzer that will allow the device to measure both anterior and posterior astigmatism. Also, leading cataract surgeons at the American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium in Deer Valley, Utah, discuss the potential to eliminate postoperative drops for pain and inflammation following cataract surgery.

Omeros Announces Initiation of Planned Pharmacokinetic Substudy in OMS302 Phase 3 Clinical Program

From Omeros Corp.

Omeros Corp. announced the initiation of the planned pharmacokinetic (PK) substudy in its phase 3 clinical program evaluating OMS302 in patients undergoing intraocular lens replacement surgery. Omeros is conducting the PK substudy to confirm the low levels of systemic exposure previously observed in preclinical studies of the drug product. Blood sa...

Login to read story

Friday, August 01, 2014

Show last days of articles

Bill Would Keep Medicaid Raise for Primary Care Through 2016

From Medscape Ophthalmology — 8/1/2014

On July 30, 2 senators introduced a bill that would extend a Medicaid raise for primary-care physicians another 2 years through 2016 and make more cli...Full story

Iluvien for Chronic Diabetic Macular Edema Receives Marketin...

From pSivida Corp. — 8/1/2014

PSivida Corp. announced that the Danish Health and Medicines Authority granted marketing authorization to Iluvien for the treatment of vision impairme...Full story

FDA to Expand Reach on Diagnostic Tests

From Medpage Today — 8/1/2014

The FDA plans to take over regulation of "home brew" diagnostic tests developed and used within individual clinical laboratories, agency officials sai...Full story

Haag-Streit UK Appointed Sole Distributor for Avellino DNA T...

From Haag-Streit UK — 8/1/2014

Haag-Streit UK has announced it has partnered with Avellino Lab USA and has been appointed the sole UK distributor of the Avellino DNA Test for LASIK ...Full story

Senate Subcommittee Explores Contact Lens Pricing and Unilat...

From VisionMonday — 8/1/2014

The issue of contact lens pricing, particularly whether new Unilateral Price Policies (UPP) being implemented this year by several major contact lens ...Full story

Thursday, July 31, 2014

New Preloaded Self-Retaining Bicanaliculus Stent II

From FCI Ophthalmics — 7/31/2014

FCI Ophthalmics has announced a new self-retaining bicanaliculus intubation set, designed by Pierre Bige, MD, according to a company news release. Cal...Full story

Kala Pharmaceuticals Initiates Phase 2 Clinical Trial to Eva...

From Kala Pharmaceuticals Inc. — 7/31/2014

Kala Pharmaceuticals announced the initiation of a phase 2 clinical trial (KPI-121-C-004) to evaluate KP-121, the company's loteprednol etabonate MPP ...Full story

Office Visits by Patients With Diabetes Rising Rapidly in US

From Medscape Ophthalmology — 7/31/2014

Office visits in the United States for diabetes rose 20% from 2005 to 2010, with the largest increase in adults in their mid-20s to mid-40s, according...Full story

Age-Related Macular Degeneration Occurs Much Earlier Than Pr...

From Medical News Today — 7/31/2014

It is widely accepted that age-related macular degeneration (AMD) is the most common cause of visual impairment and blindness in industrialized countr...Full story

Wednesday, July 30, 2014

Johnson & Johnson Vision Care Offers Testimony to US Senate ...

From Johnson & Johnson Vision Care — 7/30/2014

Millicent Knight, OD, Head of Professional Affairs, Johnson & Johnson Vision Care, Inc. today appeared before a U.S. Senate sub-committee in Washi...Full story

RPS Welcomes Peter Grady as its New Chief Financial Officer

From Rapid Pathogen Screening — 7/30/2014

Rapid Pathogen Screening announced that Peter Grady has joined RPS as Chief Financial Officer, according to a company news release. Mr. Grady has more...Full story

Amgen Says It Will Cut More Than 2,400 Jobs Worldwide

From Bloomberg — 7/30/2014

Amgen Inc., the worlds biggest biotechnology company by sales, reported second-quarter earnings that beat analysts estimates and raised its profit est...Full story

Graduate Medical Education Needs Significant Overhaul: IOM

From Medscape Ophthalmology — 7/30/2014

It is time to overhaul how graduate medical education (GME) is financed and implemented in the United States to ensure that the public's $15 billion a...Full story

Researchers Detect Love and Lust Through Eye Movements

From Medical News Today — 7/30/2014

Have you ever experienced love at first sight? What about lust at first sight? Though these two different emotional and cognitive states are difficult...Full story

Tuesday, July 29, 2014

Eylea Injection Receives FDA Approval for the Treatment of D...

From Regeneron Pharmaceuticals, Inc. — 7/29/2014

Regeneron announced that the FDA has approved Eylea (aflibercept) injection for the treatment of diabetic macular edema (DME), according to a company ...Full story

Wearable Device for the Early Detection of Common Diabetes-r...

From Applied Optics — 7/29/2014

A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it i...Full story

Study Links Loss of Vision to Employment Status

From Medical News Today — 7/29/2014

Unemployment has previously been found to have a strong connection with health and well-being. A new study published in JAMA Opthalmology has examined...Full story

Behavior Therapy May Help Prevent Depression Over Vision Los...

From Medscape Ophthalmology — 7/29/2014

For older people with central vision loss, combining occupational therapy with behavior therapy to keep them from becoming too isolated may prevent de...Full story

pSivida Announces Iluvien Receives Marketing Authorization i...

From pSivida Corp. — 7/29/2014

PSivida Corp. announced that Iluvien has been has granted marketing authorization in Norway for the treatment of vision impairment associated with chr...Full story

Monday, July 28, 2014

Alphaeon Acquires PRN Specialty Nutriceutical Company

From Alphaeon Corp. — 7/28/2014

Alphaeon, a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired Physician Recommended Nutriceuticals (PRN) of P...Full story

Deadline to Check Industry Payments to Docs Fast Approaching

From Medscape Ophthalmology — 7/28/2014

Physicians have until August 27 to review and challenge what drug and device makers have reported giving to them by way of cash or gifts as part of th...Full story

Alcon's Simbrinza Approved in the EU to Treat Patients With ...

From Alcon — 7/28/2014

Alcon announced that Simbrinza eye drops suspension (brinzolamide 10mg/mL and brimonidine tartrate 2mg/mL) has been approved by the European Commissio...Full story

Medicare Pressed to Bargain on Drug Costs

From Medpage Today — 7/28/2014

Medicare could save billions if Congress overcame its reluctance to anger the drug industry and allowed the program to demand rebates or negotiate pri...Full story

New Treatments On the Horizon to Treat Inherited Retinal Dis...

From Medical News Today — 7/28/2014

The National Institute for Health Research (NIHR) Horizon Scanning Centre (HSC), working with Fight for Sight, has identified 40 potential new treatme...Full story

Advertisement

Featured Jobs
  • General Ophthalmologist

    , FL (Statewide)

    Established over 60 years ago, one of Floridas busiest and most respected practices is seeking an experience general ophthalmologist. Ideal candidate will have an interest and experience in glaucoma or light plastics as ...